Skip to Content

Nurofen Plus (codeine/ibuprofen) – MIMS – Serious clinical harms at higher than recommended doses

01/03/2023
Medicines for human use Safety update

This article was produced by the HPRA for publication in the March edition of Monthly Index of Medical Specialties (MIMS) and describes serious clinical harms, including renal tubular acidosis and severe hypokalaemia, following prolonged use of codeine/ibuprofen at higher than recommended doses.

Documents

Opens in new window Nurofen Plus (codeine_ibuprofen) – MIMS - March 2023 PDF : 71KB | 02/07/2024